EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Adaptive Biobehavioral Control: A Pilot Analysis of Human–Machine Coadaptation in Type 1 Diabetes

Patricio Colmegna iD, Ryan McFadden, Chiara Fabris iD, Benjamin Lobo, Ralf Nass, Mary C Oliveri, Sue A Brown, Boris Kovatchev iD

Diabetes Technology & Therapeutics · 2024

DOI: 10.1089/dia.2023.0399 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Patricio Colmegna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While it is well recognized that an automated insulin delivery (AID) algorithm should adapt to changes in physiology, it is less understood that the individual would also have to adapt to the AID system. The adaptive biobehavioral control (ABC) method presented here attempts to compensate for this deficiency by including AID into an information cloud-based ecosystem.

Methods

The Web Information Tool (WIT) implements the ABC concept via the following: (1) a Physiological Adaptation Module (PAM) that tracks metabolic changes and adapts AID parameters accordingly and (2) a Behavioral Adaptation Module (BAM) that provides information feedback. The safety of WIT (primary outcome) was assessed in an 8-week randomized, two-arm parallel pilot study. All participants used the Control-IQ ® AID system enhanced with PAM, but only those in the Experimental group had access to BAM. Secondary glycemic outcomes were computed using the 2-week baseline period and the last 2 weeks of treatment.

Results

Thirty participants with type 1 diabetes (T1D) completed all study procedures (17 female/13 male; age: 40 ± 14 years; HbA1c: 6.6% ± 0.5%). No severe hypoglycemia, DKA, or other serious adverse events were reported. Comparing the Experimental and Control groups, no significant difference was observed in time in range (70–180 mg/dL): 74.6% vs 73.8%, adjusted mean difference: 2.65%, 95% CI (−1.12%,6.41%), P = 0.161. Time in 70–140 mg/dL was significantly higher in the Experimental group: 50.7% vs 49.2%, 5.71% (0.44%,10.97%), P = 0.035, without increased time below range: 0.54% (−0.09%,1.17%), P = 0.089.

Conclusion

The results demonstrate that it is safe to integrate an AID system into the WIT ecosystem. Validation in a full-scale study is ongoing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsInsulinHypoglycemic AgentsHumansPilot ProjectsFemaleMaleAdultMiddle AgedBlood GlucoseAdaptation, PhysiologicalAlgorithms

Stichwörter der Autor:innen

automated insulin deliverybiobehavioral controlcloud-based systemsself-treatment behaviorstherapy parameter adaptation

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
  • Dexcom Inc, San Diego, California, USA.
  • School of Data Science, University of Virginia, Charlottesville, Virginia, USA.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Patricio Colmegna, Chiara Fabris, Boris Kovatchev

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Colmegna, P., McFadden, R., Fabris, C., Lobo, B., Nass, R., Oliveri, M. C., Brown, S. A., & Kovatchev, B. (2024). Adaptive Biobehavioral Control: A Pilot Analysis of Human–Machine Coadaptation in Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0399

Vancouver

Colmegna P, McFadden R, Fabris C, Lobo B, Nass R, Oliveri MC, et al. Adaptive Biobehavioral Control: A Pilot Analysis of Human–Machine Coadaptation in Type 1 Diabetes. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2023.0399

BibTeX
@article{Colmegna2024,
  author = {Colmegna, Patricio and McFadden, Ryan and Fabris, Chiara and Lobo, Benjamin and Nass, Ralf and Oliveri, Mary C and Brown, Sue A and Kovatchev, Boris},
  title = {Adaptive Biobehavioral Control: A Pilot Analysis of Human–Machine Coadaptation in Type 1 Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2024},
  doi = {10.1089/dia.2023.0399}
}
Kostenlos starten →